Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E STARZL

Showing results (491-500 of 711) with videos related to

Pageof 72
Sort By:
The American Journal of Pathology|October 1, 1986
Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejectionA J Demetris, R Jaffe, D G Sheahan, et al.
Transplant Immunology|September 1, 1996
TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cellsC A Bonham, L Lu, R A Banas, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1988
Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in ratsD Kahn, G W Svanas, P K Eagon, et al.
Hepatology (Baltimore, Md.)|February 1, 1997
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functionsA Francavilla, N L Vujanovic, L Polimeno, et al.
Digestive Diseases and Sciences|January 1, 1990
Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomyD Kahn, J S Gavaler, H Lai, et al.
Digestive Diseases and Sciences|September 1, 1991
Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC)A Francavilla, C Panella, A Amoruso, et al.
Transplantation|December 10, 1998
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim reportA B Jain, I Hamad, J Rakela, et al.
The American Journal of Pathology|March 1, 1991
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitizationA J Demetris, S Qian, H Sun, et al.
Surgical Technology International|January 1, 1996
Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupressionT Gayowski, I R Marino, N Singh, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1988
Effect of partial portal vein ligation on hepatic regenerationD Kahn, M Kajani, Q Zeng, et al.
Pageof 72

Showing results (491-500 of 711) with videos related to

Sort By:
Pageof 72
The American Journal of Pathology|October 1, 1986
Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejectionA J Demetris, R Jaffe, D G Sheahan, et al.
Transplant Immunology|September 1, 1996
TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cellsC A Bonham, L Lu, R A Banas, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1988
Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in ratsD Kahn, G W Svanas, P K Eagon, et al.
Hepatology (Baltimore, Md.)|February 1, 1997
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functionsA Francavilla, N L Vujanovic, L Polimeno, et al.
Digestive Diseases and Sciences|January 1, 1990
Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomyD Kahn, J S Gavaler, H Lai, et al.
Digestive Diseases and Sciences|September 1, 1991
Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC)A Francavilla, C Panella, A Amoruso, et al.
Transplantation|December 10, 1998
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim reportA B Jain, I Hamad, J Rakela, et al.
The American Journal of Pathology|March 1, 1991
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitizationA J Demetris, S Qian, H Sun, et al.
Surgical Technology International|January 1, 1996
Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupressionT Gayowski, I R Marino, N Singh, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1988
Effect of partial portal vein ligation on hepatic regenerationD Kahn, M Kajani, Q Zeng, et al.
Pageof 72